Financial Reporting/Disclosure
| Reporting Status |
U.S. Reporting: SEC Reporting
|
| Audited Financials |
Audited |
| CIK |
0001313938 |
| Fiscal Year End |
8/31 |
| OTC Marketplace |
Pink No Information |
Profile Data
| SIC - Industry Classification |
2834 - Pharmaceutical preparations |
| Incorporated In: |
NV, USA |
| Year of Inc. |
1999 |
| Employees |
4 a/o Dec 31, 2012 |
Company Officers/Contacts
| Paul F. Petit |
President, CFO |
| Chase Zeman |
Secretary, Treasurer |
| Jean-Philippe Petit |
Vice President, COO |
| Alain S. Petit |
Vice President |
Company Directors
| Alain S. Petit |
|
| Paul F. Petit |
|
| Chase Zeman |
|
Service Providers
Accounting/Auditing Firm
|
Anton & Chia LLP
|
|
3501 Jamboree Rd.,
|
|
STE 540
|
|
Newport Beach,
CA,
92660
|
|
United States
|
| |
Securities Counsel
Investor Relations Firm
Company History
- Formerly=Naprodis Inc until 1-2015
SNNC Security Details
Share Structure
|
Market Value1 |
$876,360 |
a/o Jun 23, 2017 |
|
Authorized Shares |
60,000,000 |
a/o May 31, 2013 |
|
Outstanding Shares |
17,527,194 |
a/o Aug 31, 2015 |
|
-Restricted |
Not Available |
|
-Unrestricted |
Not Available |
|
Held at DTC |
Not Available |
|
Float |
Not Available |
|
Par Value |
0.001
|
Shareholders
| Shareholders of Record |
65 |
a/o Feb 26, 2016 |
Corporate Actions
|
Ex. Date |
Record Date |
Pay Date |
| |
| Dividends are not adjusted for stock splits |
Short Selling Data
| Short Interest |
(%)
|
| Significant Failures to Deliver |
No
|
1Market Value calculated only for respective security
